Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration

被引:108
|
作者
Fiege, B
Ballhausen, D
Kierat, L
Leimbacher, W
Goriounov, D
Schircks, B
Thöny, B
Blau, N
机构
[1] Univ Zurich, Childrens Hosp, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland
[2] Univ Zurich, Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland
[3] Schircks Lab, CH-8645 Jona, Switzerland
关键词
PKU; hyperphenylalaninemia; biopterin; NOS; endothelial dysfunction;
D O I
10.1016/j.ymgme.2003.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tetrahydrobiopterin (BH4) is widely used as a therapeutic agent in patients with BH4 deficiencies and mild forms of phenylketonuria (PKU) and there is an increasing need for the measurement of its plasma concentrations in patients with cardiovascular disorders. We measured BH4 and total biopterin in dithioerythritol (DTE) pretreated plasma from four adults after oral administration of BH4 (2, 10, and 20 mg/kg body weight) using the differential iodine oxidation method. About 80% (range 64.8-92.2%) of total biopterin was found as BH4 when analyzed immediately after blood sampling. Compared with ascorbic acid as an antioxidant, DTE was more protective against oxidation of BH4, particularly in samples stored over a period of 8 months. Without antioxidant (DTE or ascorbic acid) almost no BH4 was detected. Furthermore, BH4 and total biopterin were measured at different time intervals (up to 33 h after oral administration) and pharmacokinetic parameters T-max (1-4 h), C-max (258.7-259.0 nmol/L biopterin at a dosage of 10 mg/kg), and area under the curve (AUC=1708-1958 nmol*h/L up to T=10 h) were estimated. The elimination half-life time was calculated to be 3.3-5.1 h. Doubling the BH4 dosage to 20 mg/kg resulted in 60% higher AUC while sublingual BH4 application (2 mg/kg) resulted in 58-76% higher BH4 plasma concentrations when compared with oral administration. These preliminary data suggest that in patients with BH4 cofactor defects and BH4-responsive phenylalanine hydroxylase deficiency, BH4 should be given in at least two to three daily doses and that sublingual administration may lower the required BH4 dosage and subsequently the cost of treatment. Due to inter individual differences in pharmacokinetic properties, in some patients with hyperphenylalaninemia and mild PKU plasma BH4 levels may be not high enough to fully activate the liver phenylalanine hydroxylase and thus lower blood phenylalanine levels. Assessment of plasma BH4 or total biopterin concentrations may be a good way to control the efficacy of the loading test. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条
  • [21] Determination of Tectorigenin in Rat Plasma: Application to a Pharmacokinetic Study After Oral Administration of Tectorigenin or Its Prodrug Tectoridin
    Wei-Dong Zhang
    Lian-Wen Qi
    Xiao-Lin Yang
    Yao-Wen Lu
    Ping Li
    Zhong-Lin Yang
    Chromatographia, 2008, 68 : 1021 - 1025
  • [22] Detection of methandienone and its metabolites in equine urine, plasma and hair following a multidose oral administration
    Viljanto, Marjaana
    Love, Catherine
    White, Daniel
    Habershon-Butcher, Jocelyn
    Hincks, Pamela
    Gray, Bobby
    Scarth, James
    DRUG TESTING AND ANALYSIS, 2024, 16 (10) : 1203 - 1218
  • [23] PHARMACOKINETIC STUDIES OF DIHYDROERGOCRISTINE IN VOLUNTEERS FOLLOWING ORAL-ADMINISTRATION OF 3 FORMULATIONS
    COPPI, G
    ZANOTTI, A
    MAILLAND, F
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (11A): : 1397 - 1399
  • [24] Pharmacokinetic disposition and faecal excretion of pyrantel embonate following oral administration in horses
    Gokbulut, C
    Nolan, AM
    McKellar, QA
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2001, 24 (01) : 77 - 79
  • [25] Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys
    Aboubakr, M.
    Uney, K.
    Elmas, M.
    BRITISH POULTRY SCIENCE, 2014, 55 (01) : 115 - 119
  • [26] Pharmacokinetic modeling and Monte Carlo simulation of ondansetron following oral administration in dogs
    Baek, I. -H.
    Lee, B. -Y.
    Kang, J.
    Kwon, K. -I.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 (02) : 199 - 202
  • [27] Pilot pharmacokinetic study of oleoyl estrone following a single oral administration in rats
    Firestone, L
    Broestl, C
    Weiser, M
    Stein, J
    OBESITY RESEARCH, 2004, 12 : A138 - A138
  • [28] Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats
    Xi, Liang
    Qian, Zhiyu
    Du, Peng
    Fu, Han
    PHYTOMEDICINE, 2007, 14 (09) : 633 - 636
  • [29] Pharmacokinetic profiles of marbofloxacin following single and repeated oral administration in broiler chickens
    Patel, Harshad B.
    Patel, Urvesh D.
    Modi, Chirag M.
    Ahmed, Shaul
    Solanki, Shivani L.
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2018, 7 (02): : 174 - 179
  • [30] Pharmacokinetic analysis of two different doses of simvastatin following oral administration in dogs
    Kim, Min-Soo
    Baek, In-hwan
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2021, 44 (03) : 333 - 341